Adaptive Biotechnologies (ADPT) Retained Earnings (2018 - 2026)

Adaptive Biotechnologies has disclosed Retained Earnings across 9 years of filings, most recently posting -$1.4 billion for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$1.4 billion, down 1032455.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 billion (down 1032455.22% YoY), and the FY2025 annual result was $253000.0, up 52.41% from the prior year.
• Retained Earnings came in at -$1.4 billion for Q1 2026 at Adaptive Biotechnologies, down from $253000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $253000.0 in Q4 2025 to a low of -$1.4 billion in Q1 2026.
• The 5-year median for Retained Earnings is -$4.1 million (2022), against an average of -$416.1 million.
• Across the five-year window, Retained Earnings soared 226.42% in 2025 and slumped 1032455.22% in 2026, its largest moves.
• Adaptive Biotechnologies' Retained Earnings stood at -$4.1 million in 2022, then sank by 27702.04% to -$1.1 billion in 2023, then soared by 100.01% to $166000.0 in 2024, then soared by 52.41% to $253000.0 in 2025, then slumped by 546881.03% to -$1.4 billion in 2026.
• The last three Retained Earnings figures came in at -$1.4 billion (Q1 2026), $253000.0 (Q4 2025), and -$1.3 billion (Q3 2025), per Business Quant data.